Company news
Arbutus Biopharma Corporation (NASDAQ:ABUS) news
Every Arbutus Biopharma Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 4
Arbutus Announces Decision to Discontinue AB-452 and to Pursue Development of a Next Generation HBV Specific Oral RNA-Destabilizer
February 10, 2020
Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 6, 2019
Arbutus to Report Third Quarter 2019 Financial Results
October 30, 2019
Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B
October 3, 2019